Clinical trials
Withdrawn Cicatrix trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
28 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 1 |
| 2019 | 2 |
| 2020 | 2 |
| 2021 | 2 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 28 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Nova Scotia Health Authority | 2 |
| The University of Texas Medical Branch, Galveston | 2 |
| Ache Laboratorios Farmaceuticos S.A. | 1 |
| Boston University | 1 |
| Healthpoint | 1 |
| Icahn School of Medicine at Mount Sinai | 1 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 1 |
| Massachusetts General Hospital | 1 |
| Maternal and Child Health Hospital of Foshan | 1 |
| MiMedx Group, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Cicatrix | 28 |
| Burns | 5 |
| Cicatrix, Hypertrophic | 3 |
| Keloid | 2 |
| Acne Vulgaris | 1 |
| Breast Carcinoma In Situ | 1 |
| Carcinoma, Intraductal, Noninfiltrating | 1 |
| Diabetic Foot | 1 |
| Fibroadenoma | 1 |
| Gynecomastia | 1 |
Trials
Showing 76 to 28 of 28. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.